PDCD1 and neoplasm: suggested that the tumor cell-extrinsic mechanism of immunotherapy resistance is closely related to various immune cells within the immunosuppressive TME, which may release factors that inhibit antitumor immunity into the circulation to stimulate immune checkpoints and exhaust cytotoxic T cells (CTLs), including CTLA4 and antibodies against PD-1 (21–23).